A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

A by-product of cholesterol plays a "pivotal" role in Parkinson’s disease, according to new research. The metabolite is critical in the development of the neurodegenerative condition in mice ...

On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

While there is no cure for Parkinson’s disease, an upcoming experiment offers hope to the more than 10 million people living with the disorder that a breakthrough may be on the horizon.

Very good article Brownyn. There are more people being diagnosed with Parkinson's disease both in raw numbers of patients and in percentage of those over 50 being diagnosed. Drugs and delivery ...

The 65-year-old singer, whose “Walking in Memphis” single took the world by storm in the early ’90s, has Parkinson’s disease — a secret he revealed to fans on Thursday, January 31 ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, a new study ... Nov. 19, 2024 — A recently published study ...

Around 1 million people have Parkinson's disease in the United States, according to government data. In a late-stage study, the combination reduced the daily periods of "off episodes" by more than ...

Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The TOLEDO trial showed apomorphine ...